Investors seeking exposure beyond U.S. borders often turn to international value and dividend strategies, yet two funds in this space can look similar while behaving quite differently. AVIV and VYMI both target developed-market, large-cap equities with a value bias, making them natural candidates for the same portfolio slot. They do not compete identically, however: one is an actively managed factor strategy, while the other is a low-cost, index-based dividend fund. This ETF comparison examines their structural differences, sector exposure, cost profiles, and relative positioning to help investors decide which approach fits the current market environment.
AVIV, managed by Avantis Investors, is an actively managed fund that invests in non-U.S. developed-market large-cap companies trading at lower prices relative to their book values and earnings. The strategy blends a value screen with profitability and momentum signals, effectively tilting toward cheaper, higher-quality names. It holds roughly 600 securities, with top positions including Banco Bilbao Vizcaya Argentaria (BBVA), Safran, Shell (SHEL), Roche Holding, Rolls-Royce Holdings, BHP Group (BHP), Zurich Insurance Group, Toronto-Dominion Bank, UBS Group (UBS), and BP (BP).
Sector allocation is led by financials, followed by energy, industrials, and materials, reflecting the fund's value orientation. Country exposure is concentrated in Japan, the United Kingdom, Canada, Germany, and France. The expense ratio is 0.25%, and portfolio turnover is low, giving the fund an efficient, semi-transparent structure. AVIV's distinguishing feature is its disciplined, rules-based active approach to international value rather than a pure index replication.
VYMI is a passive exchange-traded fund that tracks the FTSE All-World ex U.S. High Dividend Yield Index. The index takes a universe of non-U.S. stocks, selects the top half by forecasted 12-month dividend yield (excluding real estate investment trusts, or REITs), and weights the result by market capitalization. This produces a broadly diversified portfolio of roughly 1,560 holdings with an expense ratio of just 0.07%.
Top holdings include HSBC Holdings (HSBC), Roche Holding, Royal Bank of Canada (RY), Novartis (NVS), Shell (SHEL), Nestlé, Mitsubishi UFJ Financial Group, BHP Group (BHP), Banco Santander (SAN), and Toyota Motor (TM). Financials are the largest sector, followed by industrials, consumer staples, and health care. Country exposure is led by Japan and the United Kingdom, with meaningful weight in Switzerland, Canada, Australia, and China. VYMI pays distributions quarterly and is oriented toward income-seeking investors who prioritize low cost and maximum diversification.
Both funds sit at the intersection of two durable themes: international diversification and value investing. In recent market cycles, non-U.S. equities have drawn renewed attention as investors seek alternatives to elevated U.S. valuations. International markets also carry heavy weightings in financials and energy — sectors that have benefited from firmer interest-rate environments and disciplined capital return among global banks and integrated energy producers. At the same time, a stronger U.S. dollar, slower growth in Europe, and geopolitical uncertainty across key regions remain persistent risks for international portfolios. Dividend-oriented strategies like VYMI have further benefited from steady demand for income, while value-tilted approaches like AVIV have leveraged the relative momentum of cheaper cyclicals. These macro currents shape both the opportunity and the risk profile of the two funds.
Over recent weeks and months, AVIV has generally outpaced VYMI, a divergence consistent with the stronger showing of deep-value and cyclical names versus the broader high-dividend universe. AVIV's active tilt toward energy, financials, and industrials has amplified its sensitivity to value rotation and the earnings cycles of its top holdings, giving it a more concentrated and potentially more volatile profile. VYMI, by contrast, has delivered steadier relative positioning through its far larger, market-cap-weighted portfolio, which dampens single-stock and single-sector risk but also reduces upside during sharp value rallies. In broad terms, AVIV represents a higher-conviction, factor-driven exposure, while VYMI represents a lower-cost, income-focused baseline. Investors weighing the two are effectively choosing between momentum-tilted value and broadly diversified dividend yield.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs with customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending stocks, and breakout candidates far more efficiently than manual screening. Explore the AI Screener to see how AI-driven filtering can sharpen your own market research.
Based on observable structural and trend factors, Tickeron's AI would currently favor AVIV. The fund combines a disciplined, profitability-adjusted value approach with stronger recent trend consistency and relative momentum across its energy, financial, and industrial exposures. Although VYMI holds clear advantages in cost efficiency and breadth of diversification, the AI's probabilistic weighting of momentum, factor exposure, and sector leadership tilts the verdict toward AVIV in the present environment. This is not investment advice but a data-informed assessment of which profile appears better positioned under current conditions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
On November 04, 2026, the Stochastic Oscillator for AVIV moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 54 instances where the indicator left the oversold zone. In 47 of the 54 cases the stock moved higher in the following days. This puts the odds of a move higher at over 87%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on AVIV as a result. In 57 of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for AVIV just turned positive on October 15, 2026. Looking at past instances where AVIV's MACD turned positive, the stock continued to rise in 31 of 41 cases over the following month. The odds of a continued upward trend are 76%.
Following a +0.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVIV advanced for three days, in 291 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
AVIV moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVIV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
AVIV broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AVIV entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where VYMI declined for three days, in 187 of 252 cases, the price declined further within the following month. The odds of a continued downward trend are 74%.
VYMI moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
VYMI broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 58 cases where VYMI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on VYMI as a result. In 63 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for VYMI just turned positive on October 15, 2026. Looking at past instances where VYMI's MACD turned positive, the stock continued to rise in 38 of 46 cases over the following month. The odds of a continued upward trend are 83%.
Following a +1.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where VYMI advanced for three days, in 281 of 335 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 303 of 373 cases where VYMI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
| AVIV | VYMI | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 87% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 80% | 2 days ago 84% |
| MACD ODDS (%) | 2 days ago 76% | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 84% | 2 days ago 85% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 81% |
| Advances ODDS (%) | 16 days ago 85% | 22 days ago 84% |
| Declines ODDS (%) | 6 days ago 71% | 6 days ago 74% |
| BollingerBands ODDS (%) | 2 days ago 68% | 2 days ago 72% |
| Aroon ODDS (%) | 2 days ago 76% | 2 days ago 81% |
A.I.dvisor indicates that over the last year, AVIV has been closely correlated with ING. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if AVIV jumps, then ING could also see price increases.
| Ticker / NAME | Correlation To AVIV | 1D Price Change % | ||
|---|---|---|---|---|
| AVIV | 100% | -0.40% | ||
| ING - AVIV | 79% Closely correlated | +0.48% | ||
| HSBC - AVIV | 77% Closely correlated | -0.38% | ||
| BBVA - AVIV | 77% Closely correlated | +0.19% | ||
| LYG - AVIV | 75% Closely correlated | -1.71% | ||
| MT - AVIV | 74% Closely correlated | +2.27% | ||
More | ||||
A.I.dvisor indicates that over the last year, VYMI has been closely correlated with NWG. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if VYMI jumps, then NWG could also see price increases.
| Ticker / NAME | Correlation To VYMI | 1D Price Change % | ||
|---|---|---|---|---|
| VYMI | 100% | -0.50% | ||
| NWG - VYMI | 70% Closely correlated | -1.68% | ||
| RIO - VYMI | 68% Closely correlated | -2.14% | ||
| BHP - VYMI | 68% Closely correlated | -2.10% | ||
| CM - VYMI | 61% Loosely correlated | -0.90% | ||
| MFG - VYMI | 58% Loosely correlated | +1.12% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SDOW | 24.05 | 0.22 | +0.92% |
| ProShares UltraPro Short Dow30 (SDOW) | |||
| QDEF | 89.67 | -0.27 | -0.30% |
| Northern Trust Quality Dividend Defensive ETF (QDEF) | |||
| IHI | 58.07 | -0.50 | -0.85% |
| iShares U.S. Medical Devices ETF (IHI) | |||
| SDEM | 32.18 | -0.31 | -0.97% |
| Global X MSCI SuperDividend Emerging Markets ETF (SDEM) | |||
| CLSX | 2.61 | -0.28 | -9.69% |
| Tradr 2X Long CLSK Daily ETF (CLSX) | |||